Katherine Widdowson
About Katherine Widdowson
Katherine Widdowson Title
Katherine Widdowson holds the position of Head of Medicinal Chemistry. In this role, she oversees the strategic direction and scientific development within the medicinal chemistry domain.
Katherine Widdowson Education and Expertise
Katherine Widdowson earned her Ph.D. in Chemistry from the California Institute of Technology. Her advanced studies and research during her Ph.D. have provided her with foundational expertise that she has applied throughout her career in medicinal chemistry.
Katherine Widdowson Background
Katherine Widdowson spent 27 years at GlaxoSmithKline (GSK), where she led the medicinal chemistry group in the Antibacterial Discovery Performance Unit. In addition to her role in antibacterial discovery, she also led the medicinal chemistry group focusing on Chronic Obstructive Pulmonary Disease (COPD).
Katherine Widdowson Achievements
During her tenure at GSK, Katherine Widdowson's group advanced four novel mechanism anti-bacterials to clinical trials: PDF, DNA gyrase, LRS (Anacor), and catechol cephalosporins (Shionogi). She also led the development of a portfolio of muscarinic receptor antagonists for COPD, including umeclidinium bromide, which is now marketed for COPD treatment.